A study on the relationship of the activity of aryl hydrocarbon receptor and aryl hydrocarbon metabolic enzymes in peripheral blood and breast cancer

王天航; 鲁英; 杨晓燕; 欧江华

doi:10.3969/j.issn.1007-3969.2014.07.006

您当前的位置：

首页 >

文章列表页 >

A study on the relationship of the activity of aryl hydrocarbon receptor and aryl hydrocarbon metabolic enzymes in peripheral blood and breast cancer

更新时间：2025-12-31

- A study on the relationship of the activity of aryl hydrocarbon receptor and aryl hydrocarbon metabolic enzymes in peripheral blood and breast cancer
- China Oncology Vol. 24, Issue 7, Pages: 512-516(2014)
- 作者机构：
  
  1. 新疆医科大学公共卫生学院,新疆,乌鲁木齐,833000
  2. 新疆医科大学附属肿瘤医院乳腺外科,新疆,乌鲁木齐,833000
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2014.07.006
  CLC：
- Published Online：29 July 2014，
  
  Published：29 July 2014
- 稿件说明：
移动端阅览
王天航,鲁英,杨晓燕,欧江华. 外周血中芳香烃受体及芳香烃代谢酶活性与乳腺癌关系的研究[J]. 中国癌症杂志, 2014, 24(7): 512-516.

王天航, 鲁英, 杨晓燕, et al. A study on the relationship of the activity of aryl hydrocarbon receptor and aryl hydrocarbon metabolic enzymes in peripheral blood and breast cancer[J]. China Oncology, 2014, 24(7): 512-516.
王天航,鲁英,杨晓燕,欧江华. 外周血中芳香烃受体及芳香烃代谢酶活性与乳腺癌关系的研究[J]. 中国癌症杂志, 2014, 24(7): 512-516. DOI： 10.3969/j.issn.1007-3969.2014.07.006.

王天航, 鲁英, 杨晓燕, et al. A study on the relationship of the activity of aryl hydrocarbon receptor and aryl hydrocarbon metabolic enzymes in peripheral blood and breast cancer[J]. China Oncology, 2014, 24(7): 512-516. DOI： 10.3969/j.issn.1007-3969.2014.07.006.

摘要

背景与目的：大量研究表明，活化的芳香烃受体(aryl hydrocarbon receptor，AhR)可能参与了由多环芳烃诱导的乳腺癌的发生，AhR作为公认的配体激活的转录因子，可诱导多种酶表达。本研究旨在探讨芳香烃受体和芳香烃代谢酶在人体内蛋白水平与乳腺癌及其病理指标间的关系。方法：以1∶1配对进行病例对照研究，共收集65对血样，采用酶联免疫吸附法检测血液中芳香烃受体及芳香烃代谢酶蛋白水平，同时收集病理资料。计量资料使用秩和检验进行统计分析，相关性分析使用Spearman检验。结果：秩和检验发现对照组与病例组间醛脱氢酶(aldehyde dehydrogenase，ALDH)、细胞色素(cytochrome P450，CYP450)差异无统计学意义(Z=0.196，P=0.845；Z=0.269，P=0.788)；AhR、醌氧化还原酶(quinone oxido-ereductase 1，NQO1)、谷胱甘肽-S-转移酶(glutatnione-S-transferases，GST)对照组平均浓度低于病例组，差异有统计学意义(Z=1.956，P=0.041；Z=2.627，P=0.009；Z=3.272，P=0.001)。相关性分析结果显示，病例组中AhR与GST和NQO1相关性较高(r=0.665，P0.01；r=0.704，P0.01)。以病理指标(ER、PR、HER-2)-、+、++、+++分组，发现以雌激素受体ER分组的AhR、GST蛋白表达水平差异有统计学意义(P0.05)。结论：实验结果显示芳香烃受体及芳香烃代谢酶蛋白水平对乳腺癌发生可能有重要影响，检测酶蛋白水平可能对乳腺癌的早期发现有帮助，对治疗方案的选择及预后有一定意义。

Abstract

Background and purpose: Previous studies showed activated aryl hydrocarbon receptor (AhR) might be involved in the development of breast cancer induced by polycyclic aromatic hydrocarbons (PHAs) and AhR which was regarded as transcription factors activated by ligand could induced many enzymes expression. Therefore

this study aimed to explore the protein level of AhR and aryl hydrocarbon metabolic enzymes in vivo with a relationship of the breast cancer and pathology indicators. Methods: A case-control study was 1∶1 matched and 65 pairs blood samples were collected

the ELISA was used in testing blood protein levels of the aromatic hydrocarbon receptor and aryl hydrocarbon metabolic enzymes. Meanwhile pathological data was collected. The Rank sum test statistical analysis was used in analyzing measurement data

Spearman test was used in correlation analysis. Results: Statistical analysis revealed that there was no statistical difference in aldehyde dehydrogenase(ALDH)

cytochrome P450(CYP450) between the case group and the control group (Z=0.196

P=0.845;Z=0.269

P=0.788);and the AhR

NQO1

GST control group concentrations were lower than that in the case group. There were statistical differences of AhR

quinone oxido-ereductase 1(NQO1)

glutatnione-S-transferases(GST) between the control group and the case group(Z=1.956

P=0.041; Z=2.627

P=0.009; Z=3.272

P=0.001). Correlation analysis showed that AhR has a higher correlation in case group with GST

NQO1 (r=0.665

P0.01; r=0.704

P0.01). Grouping with the pathology indicators (ER

HER-2) -

+++

found that the level of grouping by ER

AhR protein levels and GST protein levels have a discrepancies(P0.05). Conclusion: These results might suggest that the protein levels of AhR and aryl hydrocarbon metabolic enzymes have a significant impact on breast cancer. Detection of enzyme protein levels may be helpful for early detection of breast cancer

prompt treatment options and prognosis are meaningful.

关键词

Keywords

references

Views

3096

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)

Progress and prospects of CENPA-driven chromosomal instability in breast cancer: mechanisms, prognostic implications, and therapeutic perspectives

A study of 30-year trends in incidence and mortality risks of breast cancer among young women in China

Impact of miR-193a-3p on migration and invasion of breast cancer stem cells through targeting TRIM14

Axillary management after neoadjuvant therapy for breast cancer and optimization of sentinel lymph node diagnosis and treatment

Related Author

The Society of Breast Cancer China Anti-Cancer Association

Breast Oncology Group of the Oncology Branch of the Chinese Medical Association

LU Ye

ZHANG Wenxiang

KONG Xiangyi

FANG Yi

WANG Jing

GAO Jidong

Related Institution

Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital& Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

Shanghai Engineering Research Center of Artificial Intelligence Technology for Tumor Diseases

Department of Laboratory Medicine, Xingtai People’s Hospital

AI问答

⁰